![Humens logo](/sites/default/files/styles/etudes_thumbs/public/2024-02/logo_Humens.jpg?itok=Sr1RxrBZ)
Stories
Mid-large buyout
Biopharmaceutical company developing recombinant alkaline phosphatase therapeutics.
Healthcare - Kurma Partners
StatusIn portfolio
Investment date12/2021
SectorHealthcare
LocationEurope
Platform for paying in several installments
Venture - Digital
StatusIn portfolio
Investment date02/2022
SectorTech-enabled
LocationEurope
Hard & software trading as well as IT consulting
Direct Lending
StatusIn portfolio
Investment date02/2022
SectorTech-enabled
LocationNorth America
Installation network related to solar, electricity storage, and charging infrastructure
Venture - Smart city
StatusIn portfolio
Investment date04/2022
SectorTech-enabled
LocationEurope
Premium bee-based beauty brand
Brands
StatusIn portfolio
Investment date04/2022
SectorConsumer
LocationEurope
leading French provider of a data-centric software suite serving large financial institutions’ front-to-back-office value chain
Small-mid buyout
StatusIn portfolio
Investment date01/2023
SectorTech-enabled
LocationEurope
Eurazeo Investment Manager (EIM) and Eurazeo Mid Cap (EMC) are merging to form Eurazeo Global Investor (EGI)